Evidence for interference in estradiol-17β inactivation to estrone by oxidized low-density lipoprotein and selected lipid peroxidation products

Journal of Laboratory and Clinical Medicine

Volumn 134, Issue 3, 1999, Pages 253-259

  Abplanalp, W ^a,b   Rymaszewski, M ^a,b   Adamski, J ^a,b   Subbiah, M T R ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b Institute of Mammalian Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ANALYSIS; ENZYME MECHANISM; ESTRADIOL; ESTRONE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOW DENSITY LIPOPROTEIN; TESTOSTERONE 17BETA DEHYDROGENASE;

EID: 0033198786     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90205-6     Document Type: Article

References (36)

1. 1. Key TJA, Pike MC. The role of estrogens and progestins in epidemiology and prevelence of breast cancer. Eur J Cancer Clin Oncol 1989;24:29-44.
2. 2. Colditz GA, Stampfer MJ, Willett WC, Hennekens CH. Prospective study of estrogen replacement therapy and the risk of breast cancer in postmenopausal women. JAMA 1990;264:2648-53.
3. 3. Pasqualini JR, Gelly C, Nguyen BL, Vella C. Importance of estrogen sulphates in breast cancer. J Steroid Biochem 1989;14:155-63.
4. 4. Treileux I, Peloux N, Brown M, Sergeant A. Human estrogen receptor gene promotor-P1: estradiol independant activity and estradiol inducibility in ER+ and ER- cells. Mol Endocrinol 1997;11:1319-31.
5. 5. Reed MJ, Owen AJ, Lai LC, Coldham NG, Gilchik MW, Shaikh NA, James VHT. In situ estrogen synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxy androstenedione. Int J Cancer 1989;44:233-7.
6. 6. Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial and ovarian malignancies. Endocrinol Rev 1998;19:593-607.
7. 7. Andersson S, Moghrabi N. Physiology and molecular genetics of 17β-hydroxy steroid dehydrogenases. Steroids 1997;62:143-7.
8. 8. Labrie FL, Luu-The V, Lin S, Labrie C, Simard J, Breton R, et al. The key role of 17β-hydroxy steroid dehydrogenases in sex steroid biology. Steroids 1997;62:148-58.
9. 9. Martel C, Rheaume M, Trudel C, Couet J, Labrie F. Distribution of 17β-hydroxy steroid dehyrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol 1992;41:597-603.
10. 10. Casey ML, MacDonald PC, Andersson S. 17β-hydroxy steroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. J Clin Invest 1994;94:2135-41.
11. 11. Zhang Y, Word RA, Fesmire S, Carr BR, Rainey WE. Human ovarian expression of 17β-hydroxy steroid dehyrogenase types 1, 2, and 3. J Clin Endocrinol Metab 1996;81:3594-8.
12. 12. Adamski J, Normand T, Leenders F, Monte D, Begue A, Stenelin D, et al. Molecular cloning of a novel widely expressed human 80 kDa 17β-hydroxy dehydrogenase IV. Biochem J 1995;311:437-43.
13. 13. Jacob F, Homann DJ, Adamski J. Expression and regulation of aromatase and 17β-hydroxy dehydrogenase type 4 in human THP-1 leukemia cells. J Steroid Biochem Mol Biol 1995;55:555-63.
14. 14. Cerutti PA. Pro-oxidant states and tumour promotion. Science 1985;227:375-81.
15. 15. Frankel K. Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol Ther 1992;53:127-66.
16. 16. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE, Lee PWK. DNA-dependant protein kinase acts upstream of p53 in response to DNA damage. Nature 1998;394:700-4.
17. 17. Gowen LC, Avrutskaya AV, Latour AM, Koller BH, Leadon SA. BRCA 1 required for transcription-coupled repair of oxidative DNA damage. Science 1998;281:1009-12.
18. 18. Witztum JL. Role of oxidized lipoproteins in atherogenesis. Br Heart J 1993;69:12-8.
19. 19. Steinbrecher UP, Lougheed M, Zhang H. Biochemical basis of the receptor interaction and intracellular catabolism of oxidized LDL. Atherosclerosis Rev 1993;25:247-57.
20. 20. Fostegard J, Wu R, Giscombe R, Holm G, Lefvert A, Nilsson AKJ. Induction of T-cell activation by low density lipoprotein. Arterioscler Thromb 1992;12:461-7.
21. 21. Terkeltaub R, Banka CL, Solan J, Sontoro D. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arterioscler Thromb 1994;14:47-53.
22. 22. Hamilton TA, Guioping MA, Chisolm G. Oxidized low density lipoproteins supresses the expression of tumor necrosis factor-α mRNA in murine peritoneal macrophages. J Immunol 1990;144:2343-50.
23. 23. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-9.
24. 24. Yu BP. Cellular defences against damage from reactive oxygen species. Physiol Rev 1994;74:139-55.
25. 25. Subbiah MTR, Kessel B, Agrawal M, Rajan R, Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab 1993;77:1095-8.
26. 26. Sack MN, Radar DJ, Cannon RO III. Oestrogen inhibition of oxidation of low density lipoproteins in post menopausal women. Lancet 1994;343:269-70.
27. 27. Dupont WD, Page DL. Estrogen therapy and breast cancer. Arch Intern Med 1991;151:67-72.
28. 28. Ayers S, Abplanalp W, Liu JM, Subbiah MTR. Mechanisms involved in the protective effects of estradiol-17β on lipid peroxidation and DNA damage. Am J Physiol 1998;274:E1002-8.
29. 29. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new calorimetric method. Clin Chim Acta 1987;90:37-43.
30. 30. Kumbla L, Bhadra S, Subbiah MTR. Multifunctional role for fetuin in lipid transport. FASEB J 1991;5:2971-5.
31. 31. Tang M, Abplanalp W, Subbiah MTR. Association of estrogens with human plasma lipoproteins: studies using estradiol-17β and its hydrophobic derivative. J Lab Clin Med 1997;129:447-52.
32. 32. Barrett-Connor E, Bush TL. Estrogen and coronary artery disease in women. JAMA 1991;256:1861-9.
33. 33. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-90.
34. 34. Kovanen PT. Regulation of plasma cholesterol by hepatic low density receptors. Am Heart J 1987;113:464-9.
35. 35. Rouzer CA, Chaudhary AK, Nokubo M, Fergusson DM, et al. Analysis of malonaldehyde-2′-deoxyguanosine adduct pyrimidopurinone in human leucocyte DNA by gas chromatography/electron capture/negative chemical ionization/ mass spectrometry. Chem Res Toxicol 1997;10:181-8.
36. 36. Leenders F, Husen B, Thole HH, Adamski J. The structure of porcine 80 kDa 17β-estradiol dehyrogenase reveals similarities to the short chain alcohol dehydrogenase family, to actin binding motifs and to sterol carrier protein 2. Mol Cell Endocrinol 1994;104:127-31.